Nieuwenhuizen Natalie E, Lopata Andreas L
IIDMM, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Ann N Y Acad Sci. 2005 Nov;1056:30-45. doi: 10.1196/annals.1352.003.
Food allergy is defined as an adverse immunologic reaction to allergens present in food and is associated with symptoms ranging from gastrointestinal discomfort to anaphylactic shock and death. The increase in prevalence and potential fatality of disease has led to increased efforts to find effective therapies and prophylaxis. While specific immunotherapy (SIT) is effective in desensitization against inhalant allergens, it is unadvised against food allergy because of the high risk of adverse side effects. A review of the recent literature shows that various approaches have been taken to develop safer and more effective SIT regimens. Here we discuss the use of recombinant allergens, peptides, DNA vaccines, immunostimulatory DNA sequences, and other bacterial products in SIT. In addition, we review nonspecific therapies such as anti-IgE administration and cytokine therapy as well as natural therapies such as probiotics and Chinese herbal medications. In conclusion, anti-IgE treatment and SIT using hypoallergenic recombinant allergens in combination with Th1-inducing adjuvants appear the most promising approaches. New initiatives to increase our understanding of the pathophysiology and immunologic mechanisms of food allergy along with the molecular characterization of food allergens should pave the way towards safer and more effective ways of combating this debilitating and potentially life-threatening disease.
食物过敏被定义为对食物中存在的过敏原产生的不良免疫反应,其症状范围从胃肠道不适到过敏性休克甚至死亡。该疾病患病率的上升及其潜在的致死性促使人们加大力度寻找有效的治疗方法和预防措施。虽然特异性免疫疗法(SIT)对吸入性过敏原脱敏有效,但由于其产生不良副作用的风险很高,因此不建议用于食物过敏。近期文献综述表明,人们已采取多种方法来开发更安全、更有效的SIT方案。在此,我们讨论重组过敏原、肽、DNA疫苗、免疫刺激DNA序列及其他细菌产物在SIT中的应用。此外,我们还综述了非特异性疗法,如抗IgE给药和细胞因子疗法,以及天然疗法,如益生菌和中药。总之,抗IgE治疗以及使用低敏重组过敏原与诱导Th1佐剂联合的SIT似乎是最有前景的方法。增进我们对食物过敏病理生理学和免疫机制的理解以及对食物过敏原进行分子表征的新举措,应该会为对抗这种使人衰弱且可能危及生命的疾病开辟更安全、更有效的途径。